DANNCE.AI Secures $2.6M; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care November 24, 2024
Retrocausal Raises Oversubscribed $5.3M Round to Meet Increased Demand for its Generative AI Manufacturing Assembly Optimization Solution December 4, 2023
DANNCE.AI Secures $2.6M; Launches to Provide Clinicians and Drug Developers an AI Biomarkers Platform to Characterize Drug Effects and Optimize Neurological Care November 24, 2024
Retrocausal Raises Oversubscribed $5.3M Round to Meet Increased Demand for its Generative AI Manufacturing Assembly Optimization Solution December 4, 2023
